Supplier Type
- Reagent
- Manufacturer
- Trader
- custom synthesis
- contract manufacturer
Supplier Region
- Mumbai(75)
- Hyderabad(35)
- Gujarat(33)
- Maharashtra(35)
- Delhi(7)
- New Delhi(3)
- Andhra Pradesh(3)
- Beijing(4)
- Ahmedabad(18)
- Pune(2)
- Punjab(3)
- Bangalore(2)
- Karnataka(5)
- Telangana(3)
- Kolkata(4)
- Haryana(2)
- Himachal Pradesh(1)
- Tamil Nadu(2)
- Vadodara(5)
- Uttar Pradesh(1)
- Kerela(1)
- Rajasthan(1)
- Nagpur(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- Not less than 99.0%
- NLT95%
- NLT 98 %
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Minimum 60 Percent
- Min. 74%
- MIN .98.5%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- INDIUM INGOTS 99.995% purity
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.99%
- 99.99
- 99.98%
- 99.95%
- 99.91%
- 99.9%
- 99.86%
- 99.85%
- 99.73%
- 99.42%
- 99.3%
- 99.29%
- 99.0% Min
- 99.0%
- 99.0 % - 103.0 %
- 99%+
- 99% Min
- >99%
- 99%
- 99 %
- 98+
- 98.60%
- 98.5%
- 98.12%
- 98% Min
- 98%
- >98%
- 98 % min
- 98 %
- 97-99%
- 97-99 %
- 97.57%
- 97%
- >97%
- 97 %
- 96.80%
- 96.39%
- 96.14%
- 96%
- 95.48%
- >95%
- 95%
- 94 % , 74 %
- >92%
- >90%
- 90%
- 74% 77% 90% 94%
- 74%
- 74 to 98%
- 74
- 40%
- 35%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 0MG TO GRAM
- 25MG
- 500mg
- 1gm
- 1g
- 5g
- 25g
- 50g
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 250mg
- 10g
- 100g
- 500ml
- 500g
- 1kg
- 2500ml
- 5kg
- 10kg
- 25kg
- 50kg
- 63kg
- 74kg
- 100kg
- 250kg
- 500kg
- 1MT
- 5gms
- 25gms
- 95NLT %
- 100gms
- 200Kg drum
-
5-Bromoquinazolin-6-ylthiourea
842138-74-3
-
6-Chloro-2-(chloroMethyl)-4-(2-fluorophenyl)quinazoline 3-Oxide
60656-74-8
-
Carbamic acid, N-[[2-[2-[[(3-ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]-, methyl ester
2731586-74-4
-
Glycopyrrolate Impurity (1,1-Dimethyl-3-Hydroxy-pyrrolidinium Bromide)
51052-74-5
-
Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aR,6aS)-hexahydrofuro[2,3-b]furan-3-yl ester
799241-74-0
-
8-Chloro-6-(2-fluorophenyl)-1-methyl-6H-Imidazo[1,5-a][1,4]benzodiazepine
59469-74-8
-
(R,S,S)-Enalapril
76420-74-1
-
Olmesartan Impurity 21
885216-74-0
-
H 128/80
29122-74-5
-
Enalapril EP IMpurity A (SSR)
1356932-13-2
Ahmedabad
Product catalog:
5
Ahmedabad
Product catalog:
20
Kolkata
Product catalog:
1
Mumbai
Product catalog:
1
Ahmedabad
Product catalog:
5
C13H11Br Bromo Diphenyl Methane for Pharmaceutical Industries, Packaging Type: Bottles 776-74-9
Reagent
Note:Package: 1Kilogram;INR
Mumbai
Product catalog:
2
11-Piperazinodibenzo[b,f][1,4]thiazepine dihydrochloride 111974-74-4
Manufacturer
contract manufacturer
Ethyl (1R,5S,6R)-5-(3-pentanyloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate 347378-74-9
Trader